Eyeworld

3 EW NEWS & OPINION Sessions will highlight the present and future of world health, eye banking, and refractive surgery W orld Cornea Congress VII (WCCVII) will feature sessions focusing on the evolution and future of corneal refractive surgery and the role of the cornea in the larger picture of global eye health. The "World Health and Eye Banking" session will give attendees a comprehensive overview of ocular health issues around the globe and the role of eyecare in the context of crisis. The "Refractive Surgery" session will focus on the major refractive surgical issues that corneal surgeons face today and directions the field might take in the future. 'World Health and Eye Banking' This session, moderated by Marian S. Macsai, MD, will focus on global ocular health issues, eye banking, and providing care in emergen- cy, disaster, or conflict situations. Paul Tambyah, MD, an infectious disease specialist from Singapore, will deliver the keynote presenta- tion titled "Emerging Pandemics." Dr. Tambyah has performed exten- sive research on hospital-acquired infections as well as the growth of antimicrobial resistant infections, 2 pressing issues facing infectious disease specialists today. Patricia Dahl will present "Emer- gency Disaster Preparedness" and Matt Oliva, MD, will present "Non- standard Uses of Corneal Tissue in the Developing World." Dr. Oliva is a board member of the Himalayan Cataract Project and has worked ex- tensively to end preventable cataract blindness in developing countries. The topic will shift to treating patients in areas of conflict with Keith Wroblewski, MD, presenting "Chemical and Biological Warfare" and Capt. Anthony J. Johnson, MD, presenting "Managing War Trauma." WCCVII sessions to feature a forward-thinking perspective by Lauren Lipuma EyeWorld Staff Writer February 2015 World Cornea Congress preview The session will also highlight the importance of eye banking in corneal surgery, with Maria A. Woodward, MD, presenting "Cornea Surgery Begins in the Eye Bank: Tissue Preparation" and David B. Glasser, MD, presenting "Corneal Graft Registries." ACRYSOF® IQ INTRAOCULAR LENSES IMPORTANT PRODUCT INFORMATION CAUTION: FEDERAL (USA) LAW RESTRICTS THIS DEVICE TO THE SALE BY OR ON THE ORDER OF A PHYSICIAN. INDICATIONS: THE ACRYSOF® IQ POSTERIOR CHAMBER INTRAOCULAR LENS IS INTENDED FOR THE REPLACEMENT OF THE HUMAN LENS TO ACHIEVE VISUAL CORRECTION OF APHAKIA IN ADULT PATIENTS FOLLOWING CATARACT SURGERY. THIS LENS IS INTENDED FOR PLACEMENT IN THE CAPSULAR BAG. WARNINGS/PRECAUTIONS: CAREFUL PREOPERATIVE EVALUATION AND SOUND CLINICAL JUDGMENT SHOULD BE USED BY THE SURGEON TO DECIDE THE RISK/BENEFIT RATIO BEFORE IMPLANTING A LENS IN A PATIENT WITH ANY OF THE CONDITIONS DESCRIBED IN THE DIRECTIONS FOR USE LABELING. CAUTION SHOULD BE USED PRIOR TO LENS ENCAPSULATION TO AVOID LENS DECENTRATIONS OR DISLOCATIONS. STUDIES HAVE SHOWN THAT COLOR VISION DISCRIMINATION IS NOT ADVERSELY AFFECTED IN INDIVIDUALS WITH THE ACRYSOF® NATURAL IOL AND NORMAL COLOR VISION. THE EFFECT ON VISION OF THE ACRYSOF® NATURAL IOL IN SUBJECTS WITH HEREDITARY COLOR VISION DEFECTS AND ACQUIRED COLOR VISION DEFECTS SECONDARY TO OCULAR DISEASE (E.G., GLAUCOMA, DIABETIC RETINOPATHY, CHRONIC UVEITIS, AND OTHER RETINAL OR OPTIC NERVE DISEASES) HAS NOT BEEN STUDIED. DO NOT RESTERILIZE; DO NOT STORE OVER 45° C; USE ONLY STERILE IRRIGATING SOLUTIONS SUCH AS BSS® OR BSS PLUS® STERILE INTRAOCULAR IRRIGATING SOLUTIONS. ATTENTION: REFERENCE THE DIRECTIONS FOR USE LABELING FOR A COMPLETE LISTING OF INDICATIONS, WARNINGS AND PRECAUTIONS. LENSX® LASER IMPORTANT PRODUCT INFORMATION CAUTION: UNITED STATES FEDERAL LAW RESTRICTS THIS DEVICE TO SALE AND USE BY OR ON THE ORDER OF A PHYSICIAN OR LICENSED EYE CARE PRACTITIONER. INDICATION: THE LENSX® LASER IS INDICATED FOR USE IN PATIENTS UNDERGOING CATARACT SURGERY FOR REMOVAL OF THE CRYSTALLINE LENS. INTENDED USES IN CATARACT SURGERY INCLUDE ANTERIOR CAPSULOTOMY, PHACOFRAGMENTATION, AND THE CREATION OF SINGLE PLANE AND MULTI-PLANE ARC CUTS/INCISIONS IN THE CORNEA, EACH OF WHICH MAY BE PERFORMED EITHER INDIVIDUALLY OR CONSECUTIVELY DURING THE SAME PROCEDURE. RESTRICTIONS: PATIENTS MUST BE ABLE TO LIE FLAT AND MOTIONLESS IN A SUPINE POSITION. PATIENT MUST BE ABLE TO UNDERSTAND AND GIVE AN INFORMED CONSENT. PATIENTS MUST BE ABLE TO TOLERATE LOCAL OR TOPICAL ANESTHESIA. PATIENTS WITH ELEVATED IOP SHOULD USE TOPICAL STEROIDS ONLY UNDER CLOSE MEDICAL SUPERVISION. CONTRAINDICATIONS: CORNEAL DISEASE THAT PRECLUDES APPLANATION OF THE CORNEA OR TRANSMISSION OF LASER LIGHT AT 1030 NM WAVELENGTH. DESCEMETOCELE WITH IMPENDING CORNEAL RUPTURE. PRESENCE OF BLOOD OR OTHER MATERIAL IN THE ANTERIOR CHAMBER. POORLY DILATING PUPIL, SUCH THAT THE IRIS IS NOT PERIPHERAL TO THE INTENDED DIAMETER FOR THE CAPSULOTOMY. CONDITIONS WHICH WOULD CAUSE INADEQUATE CLEARANCE BETWEEN THE INTENDED CAPSULOTOMY DEPTH AND THE ENDOTHELIUM (APPLICABLE TO CAPSULOTOMY ONLY). PREVIOUS CORNEAL INCISIONS THAT MIGHT PROVIDE A POTENTIAL SPACE INTO WHICH THE GAS PRODUCED BY THE PROCEDURE CAN ESCAPE. CORNEAL THICKNESS REQUIREMENTS THAT ARE BEYOND THE RANGE OF THE SYSTEM. CORNEAL OPACITY THAT WOULD INTERFERE WITH THE LASER BEAM. HYPOTONY OR THE PRESENCE OF A CORNEAL IMPLANT. RESIDUAL, RECURRENT, ACTIVE OCULAR OR EYELID DISEASE, INCLUDING ANY CORNEAL ABNORMALITY (FOR EXAMPLE, RECURRENT CORNEAL EROSION, SEVERE BASEMENT MEMBRANE DISEASE). HISTORY OF LENS OR ZONULAR INSTABILITY. ANY CONTRAINDICATION TO CATARACT OR KERATOPLASTY. THIS DEVICE IS NOT INTENDED FOR USE IN PEDIATRIC SURGERY. WARNINGS: THE LENSX® LASER SYSTEM SHOULD ONLY BE OPERATED BY A PHYSICIAN TRAINED IN ITS USE. THE LENSX® LASER DELIVERY SYSTEM EMPLOYS ONE STERILE DISPOSABLE LENSX® LASER PATIENT INTERFACE CONSISTING OF AN APPLANATION LENS AND SUCTION RING. THE PATIENT INTERFACE IS INTENDED FOR SINGLE USE ONLY. THE DISPOSABLES USED IN CONJUNCTION WITH ALCON® INSTRUMENT PRODUCTS CONSTITUTE A COMPLETE SURGICAL SYSTEM. USE OF DISPOSABLES OTHER THAN THOSE MANUFACTURED BY ALCON MAY AFFECT SYSTEM PERFORMANCE AND CREATE POTENTIAL HAZARDS. THE PHYSICIAN SHOULD BASE PATIENT SELECTION CRITERIA ON PROFESSIONAL EXPERIENCE, PUBLISHED LITERATURE, AND EDUCATIONAL COURSES. ADULT PATIENTS SHOULD BE SCHEDULED TO UNDERGO CATARACT EXTRACTION. PRECAUTIONS: DO NOT USE CELL PHONES OR PAGERS OF ANY KIND IN THE SAME ROOM AS THE LENSX® LASER. DISCARD USED PATIENT INTERFACES AS MEDICAL WASTE. AES/COMPLICATIONS: CAPSULOTOMY, PHACOFRAGMENTATION, OR CUT OR INCISION DECENTRATION. INCOMPLETE OR INTERRUPTED CAPSULOTOMY, FRAGMENTATION, OR CORNEAL INCISION PROCEDURE. CAPSULAR TEAR. CORNEAL ABRASION OR DEFECT. PAIN. INFECTION. BLEEDING. DAMAGE TO INTRAOCULAR STRUCTURES. ANTERIOR CHAMBER FLUID LEAKAGE, ANTERIOR CHAMBER COLLAPSE. ELEVATED PRESSURE TO THE EYE. ATTENTION: REFER TO THE LENSX® LASER OPERATOR'S MANUAL FOR A COMPLETE LISTING OF INDICATIONS, WARNINGS AND PRECAUTIONS. © 2014 Novartis 11/14 LSX14078JAD continued on page 10 Visit our new online portal for the 2015 WCCVII Preview Program digital.cornea news.org

• Cover